Mission Wealth Management LP Has $1.19 Million Holdings in Waters Co. (NYSE:WAT)

Mission Wealth Management LP grew its holdings in Waters Co. (NYSE:WAT) by 5.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,606 shares of the medical instruments supplier’s stock after purchasing an additional 201 shares during the quarter. Mission Wealth Management LP’s holdings in Waters were worth $1,187,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Annis Gardner Whiting Capital Advisors LLC bought a new position in shares of Waters during the 3rd quarter worth approximately $33,000. Exchange Traded Concepts LLC acquired a new position in Waters during the 4th quarter valued at about $35,000. VisionPoint Advisory Group LLC increased its holdings in Waters by 300.0% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 108 shares in the last quarter. Wetzel Investment Advisors Inc. bought a new position in shares of Waters in the fourth quarter valued at approximately $39,000. Finally, Turtle Creek Wealth Advisors LLC purchased a new position in shares of Waters during the fourth quarter valued at approximately $41,000. Institutional investors own 94.01% of the company’s stock.

Insider Buying and Selling

In other Waters news, Director Linda Baddour sold 500 shares of the firm’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total value of $177,770.00. Following the completion of the transaction, the director now directly owns 2,250 shares of the company’s stock, valued at approximately $799,965. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.82% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently issued reports on WAT shares. Evercore ISI upped their target price on shares of Waters from $320.00 to $340.00 and gave the stock an “in-line” rating in a research note on Thursday, April 4th. Stifel Nicolaus increased their price objective on Waters from $290.00 to $330.00 and gave the company a “hold” rating in a report on Wednesday, February 7th. Finally, Barclays boosted their target price on Waters from $275.00 to $300.00 and gave the company an “underweight” rating in a research note on Monday, February 12th. One investment analyst has rated the stock with a sell rating and eight have given a hold rating to the company. According to MarketBeat, Waters currently has a consensus rating of “Hold” and an average price target of $298.67.

Waters Price Performance

Waters stock opened at $315.92 on Thursday. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.22 and a quick ratio of 1.57. Waters Co. has a one year low of $231.90 and a one year high of $363.80. The firm has a market capitalization of $18.74 billion, a P/E ratio of 29.12, a PEG ratio of 6.15 and a beta of 0.98. The business has a fifty day moving average price of $334.27 and a 200-day moving average price of $308.42.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 EPS for the quarter, topping the consensus estimate of $3.56 by $0.06. Waters had a return on equity of 81.30% and a net margin of 21.72%. The business had revenue of $819.50 million during the quarter, compared to the consensus estimate of $815.50 million. During the same quarter last year, the company earned $3.84 EPS. The firm’s revenue was down 4.5% compared to the same quarter last year. As a group, equities research analysts forecast that Waters Co. will post 11.89 EPS for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.